Condition 1: Polycystic ovarian syndrome. Condition 2: Hirsutism. Polycystic ovarian syndrome Hypertrichosis
Conditions
Interventions
Intervention 1: Intervention Groups: Yasmin pills (containing Drospirenone 3 mg+30 g Ethinyl Estradiol), from 1-21 day cycle for 4 months. Intervention 2: Control group: Cyproterone Compound Tablets (
Treatment - Drugs
Intervention Groups: Yasmin pills (containing Drospirenone 3 mg+30 g Ethinyl Estradiol), from 1-21 day cycle for 4 months.
Control group: Cyproterone Compound Tablets (2 mg Cyproteron acetate + 35 µg Ethinyl Estradiol) from day 21 to 1 cycle for 4 months.
Sponsors
Vice Chancellor for Research and Technology, Babol University of Medical Sciences
Eligibility
Sex/Gender
Female
Age
18 Years to 28 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: 18-28 years old nonsmoker women with polycystic ovary syndrome and Hirsutism who are raftered to our research center for treatment of Hirsutism and taking contraceptive necessities. Exclusion criteria: Hyper-prolactinemia; Hypothyroidism; diabetes; doing regular intense exercise; taking diet or herbal treatment, Non-steroidal anti- inflammatory drugs, diuretics, or hormone therapy during last 3 months.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Back spontaneous menstrual. Timepoint: 6 months after cessation of treatment. Method of measurement: Clinical examination. | — |
Secondary
| Measure | Time frame |
|---|---|
| Side effects of drugs (such as complaints of headaches and spotting). Timepoint: 4 months. Method of measurement: Clinical examination. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDr. Molod Aghajani-delavar
Fatemehzahra Infertility & reproductive Health Research Center
Outcome results
None listed